Welcome to our dedicated page for Xos SEC filings (Ticker: XOSWW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Xos's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Xos's regulatory disclosures and financial reporting.
Xos, Inc. Chief Executive Officer Dakota Semler reported a routine tax-related share disposition. On this Form 4, 14,538 shares of common stock were withheld by the company at $3.66 per share to cover tax obligations tied to previously granted Restricted Stock Unit (RSU) awards.
These shares were not sold in the open market, but retained by the issuer to satisfy withholding requirements when RSUs vested. After this transaction, Semler directly holds 832,523 shares of common stock, and the position also includes 471,975 unvested RSUs that may settle into additional shares over time.
Xos, Inc. Chief Executive Officer Dakota Semler reported a routine tax-related share disposition. On this Form 4, 14,538 shares of common stock were withheld by the company at $3.66 per share to cover tax obligations tied to previously granted Restricted Stock Unit (RSU) awards.
These shares were not sold in the open market, but retained by the issuer to satisfy withholding requirements when RSUs vested. After this transaction, Semler directly holds 832,523 shares of common stock, and the position also includes 471,975 unvested RSUs that may settle into additional shares over time.
Xos, Inc. director and Chief Operating Officer Giordano Sordoni reported a tax-related share disposition tied to vested equity awards. The company withheld 9,636 shares of common stock at $3.66 per share to cover tax obligations from vesting Restricted Stock Unit (RSU) awards, rather than an open-market sale. After this withholding, Sordoni directly owns 1,626,407 shares of Xos common stock, which includes 465,944 unvested RSUs that may convert into additional shares as they vest.
Xos, Inc. director and Chief Operating Officer Giordano Sordoni reported a tax-related share disposition tied to vested equity awards. The company withheld 9,636 shares of common stock at $3.66 per share to cover tax obligations from vesting Restricted Stock Unit (RSU) awards, rather than an open-market sale. After this withholding, Sordoni directly owns 1,626,407 shares of Xos common stock, which includes 465,944 unvested RSUs that may convert into additional shares as they vest.
Xos, Inc. Chief Financial Officer Liana Pogosyan had 3,164 shares of common stock withheld by the company at $3.66 per share to satisfy tax obligations tied to vesting of previously reported Restricted Stock Unit (RSU) awards. This is a tax-withholding disposition, not an open-market sale. Following the withholding, she directly holds 160,588 shares of common stock, which include 106,938 unvested RSUs that may convert into an equal number of shares as they vest.
Xos, Inc. Chief Financial Officer Liana Pogosyan had 3,164 shares of common stock withheld by the company at $3.66 per share to satisfy tax obligations tied to vesting of previously reported Restricted Stock Unit (RSU) awards. This is a tax-withholding disposition, not an open-market sale. Following the withholding, she directly holds 160,588 shares of common stock, which include 106,938 unvested RSUs that may convert into an equal number of shares as they vest.
Xos, Inc. director Dietmar Ostermann reported an open-market sale of 3,351 shares of Common Stock on 2026-06-08 at a weighted average price of $4.4512 per share. Footnotes state the shares were sold at prices ranging from $4.1785 to $5.1205. After this transaction, he directly holds 79,593 shares, which includes 62,377 unvested RSUs, so the sale represents only a portion of his overall stake.
Xos, Inc. director Dietmar Ostermann reported an open-market sale of 3,351 shares of Common Stock on 2026-06-08 at a weighted average price of $4.4512 per share. Footnotes state the shares were sold at prices ranging from $4.1785 to $5.1205. After this transaction, he directly holds 79,593 shares, which includes 62,377 unvested RSUs, so the sale represents only a portion of his overall stake.
Xos, Inc. director Stuart N. Bernstein reported an open-market sale of 4,000 shares of common stock on June 4, 2026 at a weighted average price of $5.2563 per share, with trade prices ranging from $5.07 to $5.4425.
Following the sale, he holds 84,058 shares of Xos common stock directly, which include 62,377 unvested RSUs. He also reports 4,133 shares held indirectly through Bernstein Investment Partners LLC, where he is the managing member.
Xos, Inc. director Stuart N. Bernstein reported an open-market sale of 4,000 shares of common stock on June 4, 2026 at a weighted average price of $5.2563 per share, with trade prices ranging from $5.07 to $5.4425.
Following the sale, he holds 84,058 shares of Xos common stock directly, which include 62,377 unvested RSUs. He also reports 4,133 shares held indirectly through Bernstein Investment Partners LLC, where he is the managing member.
Xos, Inc. is registering up to $100,000,000 of securities on a shelf basis. This shelf prospectus permits the company to offer, from time to time, Common Stock, Preferred Stock, Debt Securities, Warrants and Units in any combination, up to an aggregate amount of $100,000,000, with specific terms to be provided in prospectus supplements.
As context, the filing states that as of June 5, 2026
8,037,156 shares of Common Stock were held by non-affiliates, representing an aggregate market value of $59,957,184 based on a reported sale price of $7.46 per share on June 3, 2026working capital and general corporate purposes, and distribution methods to be set forth in supplements.
Xos, Inc. is registering up to $100,000,000 of securities on a shelf basis. This shelf prospectus permits the company to offer, from time to time, Common Stock, Preferred Stock, Debt Securities, Warrants and Units in any combination, up to an aggregate amount of $100,000,000, with specific terms to be provided in prospectus supplements.
As context, the filing states that as of June 5, 2026
8,037,156 shares of Common Stock were held by non-affiliates, representing an aggregate market value of $59,957,184 based on a reported sale price of $7.46 per share on June 3, 2026working capital and general corporate purposes, and distribution methods to be set forth in supplements.
Xos, Inc. entered into securities purchase and placement agency agreements for a registered direct offering of 1,090,910 shares of common stock at $5.50 per share. The company closed the transaction shortly after signing.
The offering generated approximately $6.0 million in gross proceeds before fees and expenses. Roth Capital Partners, LLC acted as exclusive placement agent and will receive a 6.5% cash fee on gross proceeds plus reimbursement of up to $75,000 of expenses.
Xos, Inc. entered into securities purchase and placement agency agreements for a registered direct offering of 1,090,910 shares of common stock at $5.50 per share. The company closed the transaction shortly after signing.
The offering generated approximately $6.0 million in gross proceeds before fees and expenses. Roth Capital Partners, LLC acted as exclusive placement agent and will receive a 6.5% cash fee on gross proceeds plus reimbursement of up to $75,000 of expenses.
Xos, Inc. files a prospectus supplement updating its at-the-market sales capacity under a Sales Agreement with Roth Capital Partners to up to $8,618,796 of common stock. The supplement cites a public float of $59,957,184 based on 8,037,156 shares outstanding as of June 5, 2026 and a prior 12-month issuance of $11,366,932 under the same Form S-3 instruction. The Sales Agreement pays Roth Capital Partners a 3.0% fee on aggregate gross proceeds. The prospectus supplement modifies the ATM Prospectus Supplement and Base Prospectus and is qualified by them.
Xos, Inc. files a prospectus supplement updating its at-the-market sales capacity under a Sales Agreement with Roth Capital Partners to up to $8,618,796 of common stock. The supplement cites a public float of $59,957,184 based on 8,037,156 shares outstanding as of June 5, 2026 and a prior 12-month issuance of $11,366,932 under the same Form S-3 instruction. The Sales Agreement pays Roth Capital Partners a 3.0% fee on aggregate gross proceeds. The prospectus supplement modifies the ATM Prospectus Supplement and Base Prospectus and is qualified by them.
Emerald Green Trust, a major shareholder of Xos, Inc., reported open-market sales totaling 400,000 shares of common stock over June 3–4, 2026. Reported sale prices ranged from about $4.52 to $6.52, with weighted average prices of $6.4602, $5.9697, $5.7794, and $5.0296 for the individual trades. Following these transactions, the trust held 1,241,269 shares of Xos common stock. A footnote states the sales were executed under a pre-arranged Rule 10b5-1 trading plan established on November 21, 2025, and that after the June 4 trades the trust ceased to be a beneficial owner of 10% or more of Xos’s outstanding common stock, so it is no longer subject to Section 16 reporting.
Emerald Green Trust, a major shareholder of Xos, Inc., reported open-market sales totaling 400,000 shares of common stock over June 3–4, 2026. Reported sale prices ranged from about $4.52 to $6.52, with weighted average prices of $6.4602, $5.9697, $5.7794, and $5.0296 for the individual trades. Following these transactions, the trust held 1,241,269 shares of Xos common stock. A footnote states the sales were executed under a pre-arranged Rule 10b5-1 trading plan established on November 21, 2025, and that after the June 4 trades the trust ceased to be a beneficial owner of 10% or more of Xos’s outstanding common stock, so it is no longer subject to Section 16 reporting.
Xos, Inc. is offering 1,090,910 shares of its common stock at an offering price of $5.50 per share pursuant to this prospectus supplement. The offering's aggregate public offering price is $6,000,005 with placement agent fees of $390,000 (6.5%). After placement agent fees and estimated offering expenses, estimated net proceeds to Xos are approximately $5.4 million. The prospectus states the offering will be conducted on a reasonable "best efforts" basis through Roth Capital Partners, LLC as exclusive placement agent and notes Nasdaq listing under the symbol XOS. Shares outstanding were 12,567,531 as of June 3, 2026 and are projected to be 13,658,441 after this Offering.
Xos, Inc. is offering 1,090,910 shares of its common stock at an offering price of $5.50 per share pursuant to this prospectus supplement. The offering's aggregate public offering price is $6,000,005 with placement agent fees of $390,000 (6.5%). After placement agent fees and estimated offering expenses, estimated net proceeds to Xos are approximately $5.4 million. The prospectus states the offering will be conducted on a reasonable "best efforts" basis through Roth Capital Partners, LLC as exclusive placement agent and notes Nasdaq listing under the symbol XOS. Shares outstanding were 12,567,531 as of June 3, 2026 and are projected to be 13,658,441 after this Offering.